| Serial Number | 88336123 |
| Word Mark | IMPACT |
| Filing Date | Tuesday, March 12, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, July 15, 2020 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, placental tissue for use in scientific, laboratory and medical research; bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; human amniotic membrane and human chorionic membrane for use in scientific, laboratory and medical research; human collagen and extracellular matrix compositions for use in scientific, laboratory and medical research; biological preparations for use in scientific, laboratory and medical research; biological products for use in scientific, laboratory and medical research, namely, placental-derived natural killer cells |
| Goods and Services | Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use, including for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 29, 2019 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 29, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Celularity, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Warren, NJ 07059 |
| Event Date | Event Description |
| Wednesday, July 15, 2020 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Wednesday, July 15, 2020 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Thursday, January 2, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, January 2, 2020 | FINAL REFUSAL E-MAILED |
| Thursday, January 2, 2020 | FINAL REFUSAL WRITTEN |
| Friday, December 6, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 6, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 6, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 28, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 28, 2019 | NON-FINAL ACTION E-MAILED |
| Friday, June 28, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, June 24, 2019 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, June 21, 2019 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Tuesday, May 21, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, May 21, 2019 | ASSIGNED TO EXAMINER |
| Friday, March 29, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, March 15, 2019 | NEW APPLICATION ENTERED IN TRAM |